SFB1423 was founded in 2020 and is currently in its first funding period. In the SFB1423, a total of 19 projects are being researched, divided into four areas A, B, C and Z. In addition, there are two central areas of responsibility dedicated to the administration/coordination and promotion of young researchers of SFB1423. All relevant decisions are initially made by the Executive Board, which consists of six members. The Board Meetings take place regularly once every six months. In addition, there is a Meeting of the DFG Project Leaders and the General Meeting twice a year at which all members of SFB1423 are present. Further, we install a Scientific Advisory Board in order to discuss scientific questions, receives advice on continuation of projects, topics and scientific questions.
Executive Board of the SFB1423
Annette Beck-Sickinger Coordinator / Spokesperson
Torsten Schöneberg Vice Spokesperson
Daniel Huster Head of Graduate School
Martin Lohse Project Leader
Patrick Scheerer Project Leader
Irene Coin Project Leader
Victoria Most Doctoral Representativ
Scientific Advisory Board of the SFB1423
Mario Mörl Biochemistry & Molecular Biology, Leipzig University
Heidi Hamm Cardiovascular Research, Vanderbilt University
Ad Ijzerman
Pharmacochemistry, University Leiden
Michael Freissmuth Pharmacology, Medical University Wien